Taking GLP-1s may be one of those decisions that people need to discuss and make with their doctor, knowing that taking the drug requires a long-term commitment, and it may not be the best fit for people who struggle with taking medication daily or weekly. Study conducted amidst a spike in weight loss medication market GLP-1s have surged in popularity with approximately 1 in 8 adults in the United States saying they have used them for weight loss
So it makes perfect sense that GLP-1 medications, which can lead to weight loss, have become part of this conversation
Enhances Cognitive Function : NAD+ has been shown to improve memory, focus, and overall mental clarity
The FDA has banned compounding and injection of peptides like GHK-Cu due to safety concerns
the semaglutide product approved for chronic weight management is Wegovy
For the underlying pharmacology and trial efficacy that justifies any spend on these drugs, see (Jastreboff et al., 2022) for tirzepatide SURMOUNT-1 and (Wilding et al., 2021) for semaglutide STEP-1